Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Efstathiou

Showing results (151-160 of 273) with videos related to

Pageof 28
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 17, 2023
Clinical Outcomes of De Novo Versus Relapsed Early Metastatic Testicular Seminoma Treated With Contemporary Radiation TherapyDaniel B Rosen, Anushka Ghosh, Andrzej Niemierko, et al.
Advances in Radiation Oncology|July 26, 2017
Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center experienceSophia C Kamran, Lauren C Harshman, Mandar S Bhagwat, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 3, 2017
The Rationale for Post-Operative Radiation in Localized Bladder CancerBrian C Baumann, Paul Sargos, Libni J Eapen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cellsJ A Efstathiou, D Liu, J M Wheeler, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Radiation Oncology AcaDemic Mentorship Program (ROADMAP) for Junior Faculty: One-Year Results of a Prospective Single Institution InitiativeDiana Lin, Daniel R Gomez, Yue Helen Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen LevelVinayak Muralidhar, Paul L Nguyen, Brandon A Mahal, et al.
Cancer|March 13, 2016
National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base studyBrandon A Mahal, Yu-Wei Chen, Jason A Efstathiou, et al.
The Journal of Urology|September 6, 2017
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder CancerAlejandro Sanchez, Matthew F Wszolek, Andrzej Niemierko, et al.
European Urology|November 22, 2011
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experienceJason A Efstathiou, Daphna Y Spiegel, William U Shipley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Cost implications and complications of overtreatment of low-risk prostate cancer in the United StatesAyal A Aizer, Xiangmei Gu, Ming-Hui Chen, et al.
Pageof 28

Showing results (151-160 of 273) with videos related to

Sort By:
Pageof 28
International Journal of Radiation Oncology, Biology, Physics|September 17, 2023
Clinical Outcomes of De Novo Versus Relapsed Early Metastatic Testicular Seminoma Treated With Contemporary Radiation TherapyDaniel B Rosen, Anushka Ghosh, Andrzej Niemierko, et al.
Advances in Radiation Oncology|July 26, 2017
Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center experienceSophia C Kamran, Lauren C Harshman, Mandar S Bhagwat, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 3, 2017
The Rationale for Post-Operative Radiation in Localized Bladder CancerBrian C Baumann, Paul Sargos, Libni J Eapen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cellsJ A Efstathiou, D Liu, J M Wheeler, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Radiation Oncology AcaDemic Mentorship Program (ROADMAP) for Junior Faculty: One-Year Results of a Prospective Single Institution InitiativeDiana Lin, Daniel R Gomez, Yue Helen Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen LevelVinayak Muralidhar, Paul L Nguyen, Brandon A Mahal, et al.
Cancer|March 13, 2016
National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base studyBrandon A Mahal, Yu-Wei Chen, Jason A Efstathiou, et al.
The Journal of Urology|September 6, 2017
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder CancerAlejandro Sanchez, Matthew F Wszolek, Andrzej Niemierko, et al.
European Urology|November 22, 2011
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experienceJason A Efstathiou, Daphna Y Spiegel, William U Shipley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Cost implications and complications of overtreatment of low-risk prostate cancer in the United StatesAyal A Aizer, Xiangmei Gu, Ming-Hui Chen, et al.
Pageof 28